Lipoxin A4 methyl ester – 50 µg

Brand:
Cayman
CAS:
97643-35-1
Storage:
-80
UN-No:
De Minimis - 1170 / 3

Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. LXA4 is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of 15-HETE or 15-HpETE with human leukocytes.{352} LXA4 is equipotent to leukotriene B4 (LTB4) in inducing superoxide generation in human neutrophils at 0.1 µM.{350} LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.{350,354,2722}  

 

Available on backorder

SKU: 10033 - 50 µg Category:

Description

A more lipid soluble, prodrug formulation of LXA4


Formal name: 5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid, methyl ester

Synonyms:  5(S),6(R),15(S)-TriHETE methyl ester|LXA4 methyl ester

Molecular weight: 366.5

CAS: 97643-35-1

Purity: ≥95%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Lipoxins/Resolvin Es||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Specialized Pro-Resolving Mediators||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Lipoxygenase Pathways